1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Effector Binding
1.2.3 ELISA
1.2.4 Kinetic Binding Assays
1.2.5 ADCC & CDC Cell-Based Assays
1.3 Market by Application
1.3.1 Global Biosimilar Testing and Development Services Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 PK assay
1.3.3 Tiered Immunogenicity testing
1.3.4 NAb assays
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar Testing and Development Services Market Perspective (2017-2028)
2.2 Biosimilar Testing and Development Services Growth Trends by Region
2.2.1 Biosimilar Testing and Development Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biosimilar Testing and Development Services Historic Market Size by Region (2017-2022)
2.2.3 Biosimilar Testing and Development Services Forecasted Market Size by Region (2023-2028)
2.3 Biosimilar Testing and Development Services Market Dynamics
2.3.1 Biosimilar Testing and Development Services Industry Trends
2.3.2 Biosimilar Testing and Development Services Market Drivers
2.3.3 Biosimilar Testing and Development Services Market Challenges
2.3.4 Biosimilar Testing and Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilar Testing and Development Services Players by Revenue
3.1.1 Global Top Biosimilar Testing and Development Services Players by Revenue (2017-2022)
3.1.2 Global Biosimilar Testing and Development Services Revenue Market Share by Players (2017-2022)
3.2 Global Biosimilar Testing and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biosimilar Testing and Development Services Revenue
3.4 Global Biosimilar Testing and Development Services Market Concentration Ratio
3.4.1 Global Biosimilar Testing and Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing and Development Services Revenue in 2021
3.5 Biosimilar Testing and Development Services Key Players Head office and Area Served
3.6 Key Players Biosimilar Testing and Development Services Product Solution and Service
3.7 Date of Enter into Biosimilar Testing and Development Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar Testing and Development Services Breakdown Data by Type
4.1 Global Biosimilar Testing and Development Services Historic Market Size by Type (2017-2022)
4.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2023-2028)
5 Biosimilar Testing and Development Services Breakdown Data by Application
5.1 Global Biosimilar Testing and Development Services Historic Market Size by Application (2017-2022)
5.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biosimilar Testing and Development Services Market Size (2017-2028)
6.2 North America Biosimilar Testing and Development Services Market Size by Country (2017-2022)
6.3 North America Biosimilar Testing and Development Services Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Biosimilar Testing and Development Services Market Size (2017-2028)
7.2 Europe Biosimilar Testing and Development Services Market Size by Country (2017-2022)
7.3 Europe Biosimilar Testing and Development Services Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosimilar Testing and Development Services Market Size (2017-2028)
8.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Country (2017-2022)
8.3 Asia-Pacific Biosimilar Testing and Development Services Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Biosimilar Testing and Development Services Market Size (2017-2028)
9.2 Latin America Biosimilar Testing and Development Services Market Size by Country (2017-2022)
9.3 Latin America Biosimilar Testing and Development Services Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimilar Testing and Development Services Market Size (2017-2028)
10.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2017-2022)
10.3 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Detail
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Biosimilar Testing and Development Services Introduction
11.1.4 Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.1.5 Eurofins Scientific Recent Development
11.2 SGS
11.2.1 SGS Company Detail
11.2.2 SGS Business Overview
11.2.3 SGS Biosimilar Testing and Development Services Introduction
11.2.4 SGS Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.2.5 SGS Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Detail
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Biosimilar Testing and Development Services Introduction
11.3.4 Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.3.5 Charles River Laboratories Recent Development
11.4 Pharmaceutical Product Development
11.4.1 Pharmaceutical Product Development Company Detail
11.4.2 Pharmaceutical Product Development Business Overview
11.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Introduction
11.4.4 Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.4.5 Pharmaceutical Product Development Recent Development
11.5 Exova
11.5.1 Exova Company Detail
11.5.2 Exova Business Overview
11.5.3 Exova Biosimilar Testing and Development Services Introduction
11.5.4 Exova Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.5.5 Exova Recent Development
11.6 Source BioScience
11.6.1 Source BioScience Company Detail
11.6.2 Source BioScience Business Overview
11.6.3 Source BioScience Biosimilar Testing and Development Services Introduction
11.6.4 Source BioScience Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.6.5 Source BioScience Recent Development
11.7 Intertek Group
11.7.1 Intertek Group Company Detail
11.7.2 Intertek Group Business Overview
11.7.3 Intertek Group Biosimilar Testing and Development Services Introduction
11.7.4 Intertek Group Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.7.5 Intertek Group Recent Development
11.8 Medistri
11.8.1 Medistri Company Detail
11.8.2 Medistri Business Overview
11.8.3 Medistri Biosimilar Testing and Development Services Introduction
11.8.4 Medistri Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.8.5 Medistri Recent Development
11.9 Pace Analytical Services
11.9.1 Pace Analytical Services Company Detail
11.9.2 Pace Analytical Services Business Overview
11.9.3 Pace Analytical Services Biosimilar Testing and Development Services Introduction
11.9.4 Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.9.5 Pace Analytical Services Recent Development
11.10 Sigma-Aldrich
11.10.1 Sigma-Aldrich Company Detail
11.10.2 Sigma-Aldrich Business Overview
11.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Introduction
11.10.4 Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.10.5 Sigma-Aldrich Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
